Cargando…

Cytogenetic and interphase Fluorescence in Situ Hybridization studies in patients with multiple myeloma

Detalles Bibliográficos
Autores principales:	Perumal, G, Chandra, RS, Prabu, P, Indhumathi, N, Tarigopula, Anil, Mani, Rama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044641/ http://dx.doi.org/10.1186/1755-8166-7-S1-P20

Ejemplares similares

Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India
por: Govindasamy, Perumal, et al.
Publicado: (2019)

Cytogenetic abnormality in patients with multiple myeloma analyzed by fluorescent in situ hybridization
por: Hu, Ying, et al.
Publicado: (2016)

Clonal heterogeneity by fluorescence in situ hybridization in multiple myeloma: enhanced cytogenetic risk stratification
por: Abdel-Qader, Hadeel Yaseen, et al.
Publicado: (2022)

Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma
por: Ha, Jihye, et al.
Publicado: (2022)

Interphase cytogenetics of non-Hodgkin's lymphoma using non-fluorescent in situ hybridization in paraffin embedded tissue.
por: Choi, Y. J., et al.
Publicado: (1996)

Interphase Cytogenetics of Lung Tumors Using In Situ Hybridization: Numerical Aberrations
por: Kim, Sun Young, et al.
Publicado: (1994)

Validation of interphase fluorescence in situ hybridization (iFISH) for multiple myeloma using CD138 positive cells
por: Kishimoto, Renata Kiyomi, et al.
Publicado: (2016)

Comment on: “Validation of interphase fluorescence in situ hybridization (iFISH) of CD138 positive cells in multiple myeloma”()
por: Zalcberg Renault, Ilana
Publicado: (2016)

Interphase cytogenetics of prostate cancer: fluorescence in situ hybridisation (FISH) analysis of Japanese cases.
por: Matsuura, H., et al.
Publicado: (1996)

Cytogenetic and Yq microdeletion screening studies in infertile males
por: Suganya, J, et al.
Publicado: (2014)

Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation
por: Merz, Maximilian, et al.
Publicado: (2017)

The use of fluorescence in situ hybridization techniques in the detection of microdeletion syndromes
por: ALmughamsi, Muna M, et al.
Publicado: (2014)

Oligopaints: highly efficient, bioinformatically designed probes for fluorescence in situ hybridization
por: Beliveau, Brian J, et al.
Publicado: (2013)

P-208: Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients
por: Charalampous, Charalampos, et al.
Publicado: (2022)

Detection of chromosome aberrations in interphase nuclei using fluorescence in situ hybridization technique.
por: Song, H. G., et al.
Publicado: (1993)

Combined Fluorescent-Chromogenic In Situ Hybridization for Identification and Laser Microdissection of Interphase Chromosomes
por: Paz, Nerea, et al.
Publicado: (2013)

Interphase cytogenetics of workers exposed to benzene.
por: Zhang, L, et al.
Publicado: (1996)

Interphase Cytogenetics: At the Interface of Genetics and Morphology
por: Ghadimi, B. Michael, et al.
Publicado: (1999)

Interphase fluorescence in situ hybridization analysis of fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis
por: Kiener, HP, et al.
Publicado: (2001)

Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma
por: Crabtree, Matthew, et al.
Publicado: (2022)

HER2 assessment using fluorescence in situ hybridization compared with Oncotype DX and association with risk of breast cancer death
por: Baehner, FL, et al.
Publicado: (2009)

Prenatal diagnosis of complex rearrangement of chromosome 21: The significance of interphase and metaphase fluorescence in situ hybridization and comparative genomic hybridization
por: Namba, Akira, et al.
Publicado: (2013)

Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients.
por: Zojer, N., et al.
Publicado: (1997)

Amniotic fluid interphase fluorescence in situ hybridization (FISH) for detection of aneuploidy; experiences in 130 prenatal cases.
por: Lim, Ha-Jung, et al.
Publicado: (2002)

Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma
por: Smadbeck, James, et al.
Publicado: (2019)

Fluorescence in situ hybridisation for interphase chromosomal aberration-based biological dosimetry
por: Meher, Prabodha Kumar, et al.
Publicado: (2023)

Molecular Cytogenetic Characterization of Drug‐resistant Leukemia Cell Lines by Comparative Genomic Hybridization and Fluorescence in situ Hybridization
por: Shimizu, Hajime, et al.
Publicado: (2002)

Diagnostic Utility of Multiprobe Fluorescence in situ Hybridization Assay for Detecting Cytogenetic Aberrations in Acute Leukemia
por: Kim, Bo-Ram, et al.
Publicado: (2014)

Genome-wide nucleosome mapping in multiple myeloma
por: Small, Eliza C, et al.
Publicado: (2013)

P26 LANDSCAPE OF RECURRENT CYTOGENETIC ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AS DETECTED BY CHROMOSOME MICROARRAY ANALYSIS (CMA)
por: Varshavsky Yanovsky, A., et al.
Publicado: (2023)

P931: ISATUXIMAB IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH ULTRA-HIGH-RISK CYTOGENETICS: ICARIA-MM AND IKEMA SUBGROUP ANALYSIS
por: Moreau, Philippe, et al.
Publicado: (2023)

P1279: OUTCOMES OF AUTOLOGOUS STEM CELL TRANSPLANT IN PATIENTS WITH MULTIPLE MYELOMA WITH TWO OR MORE HIGH-RISK CYTOGENETIC ABNORMALITIES
por: Pasvolsky, Oren, et al.
Publicado: (2023)

PB2081: CYTOGENETICS OF MULTIPLE MYELOMA IN MOROCCO
por: Moutmir, Yasmine, et al.
Publicado: (2023)

P01.15. Multiple Myeloma, chemotherapy and curcumin
por: Panutich, E, et al.
Publicado: (2012)

Human interphase chromosomes: a review of available molecular cytogenetic technologies
por: Vorsanova, Svetlana G, et al.
Publicado: (2010)

P891: IXAZOMIB, POMALIDOMIDE AND DEXAMETHASONE (IXPD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) CHARACTERIZED WITH HIGH-RISK CYTOGENETICS. IFM 2014-01
por: Bobin, A., et al.
Publicado: (2022)

Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization
por: Okamoto, I, et al.
Publicado: (1999)

Specific cytogenetic labeling of bovine spermatozoa bearing X or Y chromosomes using fluorescent in situ hybridization (FISH)
por: Piumi, François, et al.
Publicado: (2001)

Does the Cytogenetic Analysis Using Fluorescence In Situ Hybridization Improve the Preoperative Diagnostic Accuracy of Pancreatic Ductal Adenocarcinoma?
por: Kim, Dong Uk
Publicado: (2020)

Target fluorescence in-situ hybridization (Target FISH) for plasma cell enrichment in myeloma
por: Ma, Edmond S. K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c60jjhbhdp6n2b6aehvv73prkn